SCHEMBL845392

SCHEMBL845392

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3Cc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
HSD17B10 Q99714 1/20 0.46
USP2 O75604 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TSHR P16473 1/20 0.46
KDM1A O60341 1/20 0.46
RCOR1 Q9UKL0 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PABPC1 P11940 1/20 0.45
FKBP1A P62942 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
TRPV1 Q8NER1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871691 0.91 ALDH1A1 (0.44) ALDH1A1KDM4ELMNAHSD17B10USP2
SCHEMBL845355 0.91 ALDH1A1 (0.50) ALDH1A1KDM4ELMNAHSD17B10USP2
SCHEMBL13272392 0.89 ALDH1A1 (0.42) ALDH1A1KDM4ELMNAHSD17B10USP2
SCHEMBL845007 0.89 PABPC1 (0.49) ALDH1A1KDM4ELMNACYP2C9CYP2C19
SCHEMBL845131 0.89 PABPC1 (0.49) ALDH1A1KDM4ELMNACYP2C9CYP2C19
SCHEMBL845008 0.85 ALDH1A1 (0.54) ALDH1A1LMNACYP2C9CYP2C19TSHR
SCHEMBL13272394 0.85 MEN1 (0.47) ALDH1A1KDM4ELMNACYP2C9CYP2C19
SCHEMBL845682 0.84 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAHSD17B10USP2
SCHEMBL845005 0.83 KDM4E (0.54) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL10119320 0.83 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed